Fig. 4
From: One of the 5-aminosalicylates drug, mesalamine as a drug repurposing lead against breast cancer
TCGA survival curves using Kaplan Meier analysis. A, B represents the survival of breast carcinoma patients with high (n = 548) and low (n = 549) expression of ALOX 5 and PPARG, respectively. C, D represents survival of colorectal carcinoma patients with high (n = 185), low (n = 195) expression of ALOX 5 and high (n = 176), low (n = 204) PPARG, respectively